Feb 24 (Reuters) - GALENICA AG GALE.S:
GALENICA FOCUSES BICHSEL'S BUSINESS ON HOME CARE SERVICES
BICHSEL INTENDS TO DISCONTINUE PHARMACEUTICAL PRODUCTION BY END OF 2026 AT LATEST FOR ECONOMIC REASONS
THIS AFFECTS UP TO 170 JOBS
CONSULTATION PROCESS HAS BEEN INITIATED
IN EVENT OF CLOSURE OF BICHSEL'S PRODUCTION DIVISION, GALENICA GROUP EXPECTS ONE-OFF SPECIAL COSTS OF CHF 35-40 MILLION
DISCONTINUATION OF BUSINESS AREA WOULD IMPROVE ADJUSTED EBIT^1 OF GALENICA GROUP BY AROUND CHF 3 MILLION PER YEAR FOLLOWING ITS CLOSURE AT END OF 2026
Source text: ID:nEQ2kMlXxa
Further company coverage: GALE.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))